Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke

NCT04256473 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: mutant pro-urokinase
DRUG: Alteplase

Sponsor

Erasmus Medical Center

Collaborators

[object Object]